| 2026 | AASLD | Analytical Validation of a Serum miRNA RT-qPCR Assay for Monitoring Allograft Liver Rejection | Available on Nov. 10 |
| 2026 | AASLD | Development of a Clinically Scalable Circulating microRNA Assay for Liver Fibrosis Staging in MASH | Available on Nov. 10 |
| 2026 | AACR | Comprehensive cytokine, chemokine and immune marker evaluation in plasma samples of primary, non-metastatic high grade serous ovarian cancer patients to estimate outcome and platinum resistance. | PDF |
| 2025 | EORTC | Comprehensive cytokine and chemokine evaluation in plasma samples of primary, non-metastatic high grade serous ovarian cancer patients to estimate out come and platinum resistance | PDF |
| 2025 | WTC | Analytical Validation of a Serum miRNA RT-qPCR Assay for Monitoring Allograft Liver Rejection | PDF |